Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Feb 2020
Historique:
received: 19 12 2019
revised: 06 02 2020
accepted: 06 02 2020
entrez: 16 2 2020
pubmed: 16 2 2020
medline: 15 12 2020
Statut: epublish

Résumé

The melanocortin 4 receptor (MC4R) is a key player in hypothalamic weight regulation and energy expenditure as part of the leptin-melanocortin pathway. Mutations in this G protein coupled receptor (GPCR) are the most common cause for monogenetic obesity, which appears to be mediated by changes in the anorectic action of MC4R via G

Identifiants

pubmed: 32059383
pii: ijms21041224
doi: 10.3390/ijms21041224
pmc: PMC7072973
pii:
doi:

Substances chimiques

Leptin 0
Ligands 0
MC4R protein, human 0
Melanocortins 0
Receptor, Melanocortin, Type 4 0
Receptors, G-Protein-Coupled 0
alpha-MSH 581-05-5
Cyclic AMP E0399OZS9N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Obesity (Silver Spring). 2008 Feb;16(2):369-76
pubmed: 18239646
J Clin Invest. 2016 Jan;126(1):40-9
pubmed: 26595811
Front Pharmacol. 2019 Sep 13;10:1027
pubmed: 31572197
Handb Exp Pharmacol. 2012;(209):47-75
pubmed: 22249810
J Surg Res. 2006 May 15;132(2):201-7
pubmed: 16580690
Trends Mol Med. 2019 Feb;25(2):136-148
pubmed: 30642682
Nat Genet. 1998 Oct;20(2):111-2
pubmed: 9771698
Nat Med. 2018 May;24(5):551-555
pubmed: 29736023
Obes Res. 2004 Jul;12(7):1060-6
pubmed: 15292469
J Bone Miner Res. 2000 Sep;15(9):1697-706
pubmed: 10976990
Obesity (Silver Spring). 2010 Mar;18(3):573-9
pubmed: 19696756
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5754-8
pubmed: 6777774
Am J Hum Genet. 2004 Mar;74(3):572-81
pubmed: 14973783
Cell. 2019 Apr 18;177(3):597-607.e9
pubmed: 31002796
Int J Obes (Lond). 2007 Sep;31(9):1437-41
pubmed: 17356525
BMC Med Genet. 2009 Mar 12;10:25
pubmed: 19284607
J Clin Endocrinol Metab. 2004 Feb;89(2):940-5
pubmed: 14764818
Hum Genet. 2009 Jan;124(6):633-47
pubmed: 19011902
Cell Metab. 2006 Feb;3(2):141-6
pubmed: 16459315
Peptides. 2006 Nov;27(11):2846-57
pubmed: 16806584
Nat Neurosci. 2005 May;8(5):571-8
pubmed: 15856065
Endocrinology. 2005 Dec;146(12):5257-66
pubmed: 16166226
Front Endocrinol (Lausanne). 2019 Jul 31;10:515
pubmed: 31417496
Br J Pharmacol. 2016 Apr;173(8):1393-403
pubmed: 26791140
Mol Endocrinol. 2013 Nov;27(11):1934-45
pubmed: 24085819
Am J Hum Genet. 2007 Apr;80(4):779-91
pubmed: 17357083
Regul Pept. 2001 May 5;99(1):1-7
pubmed: 11257308
Hum Mol Genet. 2003 Jan 15;12(2):145-53
pubmed: 12499395
Nat Genet. 1998 Oct;20(2):113-4
pubmed: 9771699
J Biochem. 2004 Apr;135(4):541-6
pubmed: 15115780
J Mol Endocrinol. 2013 Jun 29;51(1):109-18
pubmed: 23674133
Horm Res Paediatr. 2012;78(4):237-46
pubmed: 23146882
J Clin Endocrinol Metab. 2003 Sep;88(9):4258-67
pubmed: 12970296
Hum Mol Genet. 2007 Aug 1;16(15):1837-44
pubmed: 17519222
Diabetes. 2012 Jan;61(1):250-7
pubmed: 22106157
Peptides. 2005 Oct;26(10):1842-7
pubmed: 15982783
Regul Pept. 2004 Aug 15;120(1-3):113-8
pubmed: 15177928
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
Mol Endocrinol. 1999 Jan;13(1):148-55
pubmed: 9892020
Biochemistry. 2006 Jun 13;45(23):7277-88
pubmed: 16752916
J Med Genet. 2005 Apr;42(4):e21
pubmed: 15805150
J Biol Chem. 2009 Sep 25;284(39):26411-20
pubmed: 19648111
Cell. 2019 Jun 13;177(7):1933-1947.e25
pubmed: 31160049
Mol Endocrinol. 2001 Jan;15(1):164-71
pubmed: 11145747
J Clin Endocrinol Metab. 2006 May;91(5):1761-9
pubmed: 16492696
J Clin Invest. 2000 Jul;106(2):253-62
pubmed: 10903341
Brain Res. 2003 Oct 3;986(1-2):1-11
pubmed: 12965224
PLoS One. 2007 Aug 01;2(7):e668
pubmed: 17668051
Science. 2013 Jul 19;341(6143):278-81
pubmed: 23869017
Obesity (Silver Spring). 2016 Sep;24(9):1976-82
pubmed: 27474872
Mol Pharmacol. 2017 Oct;92(4):414-424
pubmed: 28679508
Nat Commun. 2019 Oct 25;10(1):4897
pubmed: 31653860
J Biol Chem. 1993 Jul 15;268(20):15174-9
pubmed: 8392067
J Neurochem. 2001 Sep;78(5):981-90
pubmed: 11553672
J Neuroendocrinol. 2019 Oct;31(10):e12795
pubmed: 31529534
J Endocrinol. 2010 Nov;207(2):177-83
pubmed: 20696697
Diabetes. 2003 Dec;52(12):2984-8
pubmed: 14633860
J Cell Mol Med. 2009 Sep;13(9B):3268-82
pubmed: 19298524
Mol Biol Rep. 2014 Mar;41(3):1491-500
pubmed: 24385306
Eur J Pharmacol. 1995 Feb 15;288(3):311-7
pubmed: 7774675
J Biomol Screen. 2009 Mar;14(3):246-55
pubmed: 19211780
Diabetes. 1999 Mar;48(3):635-9
pubmed: 10078568
J Biol Chem. 1999 Dec 10;274(50):35816-22
pubmed: 10585465
Biochim Biophys Acta. 2013 Dec;1832(12):1939-48
pubmed: 23791567
J Pediatr. 2007 Jun;150(6):618-22, 622.e1-5
pubmed: 17517246
Front Pharmacol. 2018 Mar 12;9:222
pubmed: 29593543
Peptides. 2006 Feb;27(2):372-9
pubmed: 16289450
Int J Biol Sci. 2014 Oct 09;10(10):1128-37
pubmed: 25332687
Nat Commun. 2018 Jan 23;9(1):341
pubmed: 29362459

Auteurs

Sarah Paisdzior (S)

Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany.

Ioanna Maria Dimitriou (IM)

Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany.

Paul Curtis Schöpe (PC)

Max Delbrück Center, Robert-Rössle-Straße 10, 13092 Berlin, Germany; Institute of Pharmacology and Toxicology, University of Würzburg, D-97078 Würzburg, Germany.

Paolo Annibale (P)

Max Delbrück Center, Robert-Rössle-Straße 10, 13092 Berlin, Germany; Institute of Pharmacology and Toxicology, University of Würzburg, D-97078 Würzburg, Germany.

Patrick Scheerer (P)

Group Protein X-ray Crystallography and Signal Transduction, Institute of Medical Physics and Biophysics, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany.

Heiko Krude (H)

Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany.

Martin J Lohse (MJ)

Max Delbrück Center, Robert-Rössle-Straße 10, 13092 Berlin, Germany; Institute of Pharmacology and Toxicology, University of Würzburg, D-97078 Würzburg, Germany.

Heike Biebermann (H)

Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany.

Peter Kühnen (P)

Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-10117 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH